Showing results (1291-1300 of 1,479) with videos related to

Sort By:
Pageof 148
The Lancet. Oncology|March 29, 2023
Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials ConferenceRifaquat Rahman, Mei-Yin C Polley, Laura Alder, et al.
Nature Communications|January 9, 2020
BCL9 provides multi-cellular communication properties in colorectal cancer by interacting with paraspeckle proteinsMeng Jiang, Yue Kang, Tomasz Sewastianik, et al.
The Journal of Clinical Investigation|January 7, 2015
Telomerase mutations in smokers with severe emphysemaSusan E Stanley, Julian J L Chen, Joshua D Podlevsky, et al.
Nature Chemical Biology|November 22, 2025
Dynamic metal coordination controls chemoselectivity in a radical halogenaseElijah N Kissman, Ioannis Kipouros, Jeffrey W Slater, et al.
Iscience|December 5, 2022
Hepatocyte-derived GDF15 suppresses feeding and improves insulin sensitivity in obese miceBingxian Xie, Anjana Murali, Amber M Vandevender, et al.
Plos One|May 16, 2012
Plasma Plasmodium falciparum histidine-rich protein-2 concentrations are associated with malaria severity and mortality in Tanzanian childrenMatthew P Rubach, Jackson Mukemba, Salvatore Florence, et al.
Molecular & Cellular Proteomics : MCP|August 6, 2014
The GalNAc-type O-Glycoproteome of CHO cells characterized by the SimpleCell strategyZhang Yang, Adnan Halim, Yoshiki Narimatsu, et al.
Science (New York, N.Y.)|October 2, 2020
Phasing of millennial-scale climate variability in the Pacific and Atlantic OceansMaureen H Walczak, Alan C Mix, Ellen A Cowan, et al.
Iscience|August 9, 2023
Down syndrome is associated with altered frequency and functioning of tracheal multiciliated cells, and response to influenza virus infectionSamantha N Thomas, Brian F Niemeyer, Rocio J Jimenez-Valdes, et al.
The Lancet. Infectious Diseases|December 24, 2019
Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trialMichael S Niederman, Jeff Alder, Matteo Bassetti, et al.
Pageof 148